News from MESA: expert interviews
MESA is sharing three interviews with malaria experts published by the World Health Organization. Fred Binka, Rose Leke and Marcel Tanner have been interviewed. Read the MESA announcement ‘WHO Global Malaria Programme shares 'A word from the experts' here.
Start pilot malaria vaccinations in 2018
On 17 November the World Health Organization announced that in 2018 the world’s first malaria vaccine RTS,S will be rolled out in pilot projects in sub-Saharan Africa. Read ‘The world's first malaria vaccine set to roll out in 2018’ here.
Blog: Artemisinine & Malaria
In his series Pierre Lutgen focuses this week on immunodepression and malaria blocking and refers to several studies. Read ‘Artesunate causes immunodepression, Artemisia afra blocks malaria transmission’ here.
Enjoy this week's MalariaWorld - the MW team
Support MalariaWorld to provide Open Access to malaria information for all. We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at email@example.com
MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, you don’t pay to read, and authors get paid € 150 for each published paper. Read about MW and how you can submit your manuscript here.
Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to www.malariaworld.org, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.
The World Health Organization confirmed on 17 November that the world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa. Vaccinations will start in 2018.
The vaccine, known as RTS,S, acts against P. falciparum, the most deadly malaria parasite globally, and the most prevalent in Africa. Advanced clinical trials have shown RTS,S to provide partial protection against malaria in young children.
This infographic displays data from the World Health Organization’s “Projections of mortality and causes of death, 2015 and 2030”. The report details all deaths in 2015 by cause and makes predictions for 2030, giving an impression of how global health will develop over the next 14 years. Also featured is data from geoba.se showing how life expectancy will change between now and 2030.
SciDev.Net article - 21-09-2016
illumigene® Malaria, a novel, highly accurate test developed by Meridian Bioscience, has been awarded the coveted Journées Internationales de Biologie prize for Innovation in emergency treatment and point of care testing.
I am delighted to welcome Dr Fred Binka as Coordinator of WHO’s Emergency Response to Artemisinin Resistance (ERAR) hub in Phnom Penh, Cambodia.
Dear Partners and Friends,
After a period of extensive consultation, the RBM Board agreed at its 29th Meeting in December 2015 on a new governance architecture. This included the establishment of a reconstituted Partnership Board, which could take advantage of the tremendous skill, energy and effectiveness of its partners and lead the organization into a new era.
Dr Sylvia Meek meets with community drug distributors supported by our integrated community case management and nutrition project
ACT Consortium launches free resources for malaria community
On World Malaria Day, ACT Consortium researchers launched five resources to help guide those working in malaria endemic countries.